The Global Drug Delivery Technologies Market will reach $138.1BN, According to A New Report on ASDReports

Monday 2 June 2014, Amsterdam

A new report, now available on ASDReports, calculates that the global drug delivery technologies market will reach $138.1bn in 2014 with revenues showing strong growth to 2024. These revenue forecasts and others appear in the latest 202 page report Drug Delivery Technologies Market Forecast 2014-2024: Opportunities for Leading Companies.

Drug delivery technologies provide a wide scope for line extensions and the development of new products. These technologies give pharmaceutical companies choices in terms of the delivery mechanism to be employed for their products; this is especially useful in the administration of large-molecule agents. Drug delivery encompasses reformulations, such as extended release, as well as drug delivery devices like inhalers and injection systems. Drug delivery is an aspect of the research and development phase that has been overlooked somewhat in the past. It was seen as an essential but otherwise uninteresting part of the industry that rarely inspired innovation. Experimental approaches were, by and large, viewed as useful tools to assist near the end of a product's lifecycle and often regarded as the domain of specialist pharma companies. However, as the pressures and competition within the pharma industry has increased, drug delivery programmes of all types have become increasingly important earlier in the drug development cycle.

Moses Akintomide-Akinwamide, a pharmaceutical and medical technology market analyst explains: “As some key products continue to lose patent protection and the market for some biotech drugs becomes more crowded, drug manufacturers will introduce new and innovative modes of administration into the market in order to help them retain exclusivity. The need to optimize a drug’s therapeutic value and the quest to find ways of getting a drug into a patient’s system in safer and more consistent ways have been major driving factors for growth in the drug delivery technologies market. Novel drug delivery technologies are being used to achieve better compliance and outcomes for drugs. Furthermore, many new drugs, especially biologics and vaccines, cannot be taken in the traditional oral ways, so the impetus to create innovative delivery platforms is strong and growing. Strategic collaborations, self administration, the introduction of innovative home care drug delivery devices, and the expanding applications of drug delivery into niche therapeutic areas represent vast opportunities for companies operating in this market.”

Economically developed countries in North America and Europe dominated the drug delivery technologies market in 2013. The rising incidence in a number of illnesses, such as diabetes, will be a major driver of growth in the drug delivery technologies market over the forecast period. The increase in the proportion of the population at risk of conditions such as cardiovascular diseases will increase the need for therapies and delivery systems to maximise the therapeutic effects of the available therapies. The major national markets in Europe are expected to face stiff competition from the emerging economies of China and India between 2014 and 2024. These emerging markets are expected to witness strong growth during the forecast period, with government subsidies and healthcare expansion plans aiding their growth.

The new report provides revenue forecasts to 2024 for the global drug delivery technologies market and the leading regional markets. It forecasts sales in the US, Japan, Germany, France, Italy, Spain, UK, China, India, Russia, Brazil, Mexico and South Korea.

The report also forecasts sales for subsectors of the drug delivery technologies market, including transdermal drug delivery technologies, oral drug delivery technologies, inhalation drug delivery technologies, injectable/implantable drug delivery technologies, nasal drug delivery technologies, and ocular drug delivery technologies.

Forecast and analysis for the global biological drugs market is also provided in the report. The report forecasts sales for subsectors of the biological drugs market, including monoclonal antibodies, interferons, Insulins, granular colony stimulating factors (G-CSF), erythropoietins, and recombinant coagulation factors. Forecasts for the global biosimilars market and the global vaccines market are also provided. The report also includes exclusive  interviews with two key opinion leaders in the industry sharing their views on current market trends and the unmet needs in the market.

Drug Delivery Technologies Market Forecast 2014-2024: Opportunities for Leading Companies adds to the extensive range of analytical reports on industries and markets in healthcare.